Results for tag: "Eloxatin"

Eloxatin (oxaliplatin) is a chemotherapy drug used to treat colorectal cancer. It is a platinum-based drug that works by interfering with the growth of cancer cells, preventing them from dividing and spreading. Eloxatin is usually used in combination with other drugs, such as 5-fluorouracil and leucovorin, to treat advanced colorectal cancer. It is also used to treat other types of cancer, such as ovarian and gastric cancer. Eloxatin is generally well tolerated, but can cause side effects such as nausea, vomiting, and hair loss. The Eloxatin market is highly competitive, with several major players offering similar products. The market is driven by the increasing prevalence of colorectal cancer, as well as the growing demand for more effective treatments. Additionally, the development of new drugs and technologies has enabled the market to expand. Some of the major companies in the Eloxatin market include Sanofi, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more